Investigating in Vivo and in Vitro Effects of Ethanolic and Aqueous Extracts of Myrtle (Myrtus communis) on Leishmania major
Background: The extract of myrtle plant contains polyphenolic compounds that show antibacterial, antiviral, and anti-parasitic properties. We aimed to investigate the therapeutic effect of aqueous and ethanolic myrtle extract against leishmaniasis caused by L. major in vivo and in vitro conditions.
Methods: This study was carried out in Tarbiat Modares University, Tehran, Iran in 2018. Aqueous and ethanolic extract of myrtle plant at 6.25 to 400 mg/ml concentrations were tested on Leishmania major promastigotes, non-infected macrophages, and macrophages infected with amastigotes in vitro using counting, MTT and flow cytometry techniques. Then, BALB/c mice were treated with ethanolic, aqueous and a mixture of both extracts of myrtle plant. The treatment was carried out for four weeks. Then, the effectiveness of the herbal medicine was assessed by measuring wounds diameters, mice weights and their mortality rate on weekly basis.
Results: The IC50 values of aqueous and ethanolic extracts for promastigotes were 7.86 and 11.66 μg/mL respectively. The IC50 values of the aqueous and ethanolic extracts for amastigotes were 12.5 and 47.2 μg/mL respectively. Flow cytometry indicates 62.88% and 60.16% apoptosis induced by ethanolic and aqueous extract of myrtle plant respectively. The lowest parasitic load was seen in the group treated with ethanolic extract.
Conclusion: The lesion sizes for treated groups with extracts were similar to those treated with glucantime. Oral administration instead of injection is another advantage of myrtle plant over glucantime, which makes the herb easy and more practical.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–18.
3. Reithinger R, Dujardin JC, Louzir H et al. Cutaneous leishmaniasis. Lancet Infect Dis. 1999; 7:581–596.
4. Salman SM, Rubeiz NG, Kibbi AG. Cuta-neous leishmaniasis: clinical features and diagnosis. Clin Dermatol. 1999; 17:291–6.
5. Akhoundi M, Kuhls K, Cannet A, P, et al. A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies. PLoS Negl Trop Dis. 2016;10(3):e0004349.
6. Ghaffarifar F, Esavand Heydari F, et al. Evaluation of apoptotic and antileishmanial activities of artemisinin on promastigotes and BALB/C mice infected with Leishmania major. Iran J Parasitol. 2015; 10(2): 258-267.
7. Bonjar GS. Antibacterial screening of plants used in Iranian folkloric medicine. Fitoterapia. 2004;75(2):231-5.
8. Moradi MT, Karimi A, Rafieian M, et al. The inhibitory effects of myrtle (Myrtus communis) extract on Herpes simplex virus-1 replication in Baby Hamster Kidney cells. J Shahrekord Univ Med Sci. 2011; 12 (4): 54-61.
9. Yadegarinia D, Gachkar L, Rezaei MB, et al. Biochemical activities of Iranian Mentha piperita L. and Myrtus communis L. essential oils. Phytochemistry. 2006; 67(12):1249–55.
10. Mendes MM, Gazarini LC, Rodrigues ML. Acclimation of Myrtus communis to contrasting Mediterranean light environments: effects on structure and chemical composition of foliage and plant water relations. Environmental and Experimental Botany. 2001;45:165–78.
11. Aleksic V, Knezevic P. Antimicrobial and antioxidative activity of extracts and essential oils of Myrtus communis L.Microbiological Research 2014; 169(240-254).
12. Snow N, McFadden J, Evans TM, et al. Morphological and molecular evidence of polyphyly in rhodomyrtus (Myrtaceae: Myrteae). Systematic Botany. 2011;36:390–404.
13. Twaij HA, Ali HM, Al-Zohyri AM. Phytochemical and antimicrobial studies of Myrtus communis. J Biol Sci Res. 1988;19:29–39.
14. Romani A, Pinelli P, Mulinacci N, et al. Identification and quantification of polyphenols in leaves of Myrtus communis L. Chromatographia. 1999;49:17–20.
15. Baytop T. Therapy with medicinal plants in Turkey (past and present). Istanbul: Nobel Medical Press; 1999.
16. Mahmoud IN, El-Sayed AA, Rania FA, et al. Secondary metabolites and bioactivities of Myrtus communis. Pharmacognosy Res. 2010; 2(6):325–329.
17. Aleksic V, Knezevic P. Antimicrobial and antioxidative activity of extracts and essential oils of Myrtus communis L. Microbiol Res. 2014; 169(4):240-54.
18. Barati M, Sharifi I, Fariba Sharififar F. In vitro Evaluation of Anti-Leishmanial Activities of Zataria multiflora Boiss, Peganum harmala and Myrtus communis by Colorimetric Assay. J Kerman Univ Medical Sci. 2010; 16(1):32-42.
19. Sumbul S, Ahmad MA, Asif M, et al. Myrtus communis Linn. A review. Indian J Nat Prod Resour. 2011;2(4):395-402.
20. Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytotherapy Res. 2014;28(8):1125-36.
21. Mimica-Dukić N, Bugarin D, Grbović S, et al. Essential oil of Myrtus communis L. as a potential antioxidant and antimutagenic agents. Molecules. 2010;15(4):2759-70.
22. Babaee Khou L, Mohebali M, Niakan Lahiji, et al. The therapeutic effects of Eucalyptus, Myrtus, Ferula, Aretmisia, Allium and Urtica extracts against cutaneous leishmaniasis caused by Leishmanaia major in small white mice (out- bred). Hakim Res J. 2007; 10(2):21-27.
23. Mirzaian H, Ghaffarifar F, Sadraei J, et al. Evaluation the effects of aqueous and alcoholic extracts of Myrtus communis L. on tachyzoites of Toxoplasma gondii in vitro. Iranian Journal of Medicinal and Aromatic Plants. 2019; 35(2):276-290.
24. Mahmoudvand H, Ezzatkhah F, Sharififar F, et al. Antileishmanial and Cytotoxic Effects of Essential Oil and Methanolic Extract of Myrtus communis L. Korean J Parasitol. 2015; 53(1): 21-7.
|Issue||Vol 16 No 4 (2021)|
|Ethanolic and aqueous extracts Myrtus communis Leishmania major In vitro BALB/c mice|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|